Mike Nally is President of Global Vaccines at MSD. MSD, with a $6 billion vaccines business, is a global leader providing a broad portfolio of pediatric, adolescent, and adult vaccines to the world. In his role, Mike aims to drive a dramatic increase in the reach and public health impact of vaccines, while delivering business growth. Prior to this appointment, Mike led the company's business in Sweden and the UK, focusing on the development and implementation of innovative, customer-centered approaches that delivered improved business results and accelerated patient access to our medicines. Previously, Mike was Executive Director of Strategic Initiatives and Operations and has also held positions in Finance, Business Development and in Investor Relations. Mike holds a MBA from Harvard Business School, a degree in Accounting and Finance from the London School of Economics and a BA in Economics from Middlebury College.